Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses

Award Number: R01ES030425
ORGANIZATION: NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2019
PERIOD OF PERFORMANCE END DATE: 04/30/2026

Group Awards By:

View Award Description

Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses - Abstract Ultraviolet B radiation (UVB) is an environmental carcinogen, which is one of the major causative factors of skin cancer formation. Activation of NF-kB has been shown to play an important role in carcinogenesis by inhibiting apoptosis and therefore enhancing cell transformation. Thus, the NF-kB signaling network has been a major target for development of therapeutics for prevention of UVB-induced skin carcinogenesis. We reported a non-canonical pathway for activation of NF-kB that is mediated by constitutive nitric oxide synthase (cNOS) in the early phase (6 h) after UVB irradiation. At the same time, activation of cNOS is expected to promote cell damage by producing toxic peroxynitrite (ONOO−) from nitric oxide (NO•) and superoxide (O2−•). Therefore, UVB-induced activation of cNOS promotes skin carcinogenesis by increasing the extent of DNA damage, decreasing the capacity of DNA damage repair and promoting the survival of damaged cells. This finding suggests that cNOS inhibitors could protect against development of skin cancer via blocking the synergistic effect of DNA damage and anti-apoptotic activity of NF-kB. A desirable property of cNOS as a target is that it only affects UVB-induced but not TNFa-induced NF-kB activation. The objective of this proposal is to elucidate the fundamental molecular mechanism of UVB-induced skin carcinogenic responses through a detailed study of cNOS-coordinated pro-death oxidative/nitrosative stress and DNA damage as well as pro-survival NF-kB activation and autophagy induction. The innovation of this proposal resides on the novel hypotheses that UVB-induced early phase NF-kB activation is solely dependent on cNOS activation; and cNOS is a promising potential target for chemoprevention of UVB-induced skin carcinogenesis. This hypothesis is based on the oncogenic properties of cNOS in causing DNA damage, activating NF-kB, and inducing autophagy via NF-kB-regulated stabilization of IKKa. In addition, the proposed mechanism for regulation and the functional role of NF-kB-IKKa signaling cascade is a novel conceptual ‘reversal’ of the normal IKKa-NF-kB signaling. The therapeutic use of cNOS inhibitors in preventing UVB-induced DNA damage, cell death, as well as skin carcinogenesis is clinically innovative. The proposed study can potentially lead to the development of new therapeutics for chemoprevention and treatment of UVB-induced skin cancer.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$80 )
2026	2023	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	5	6/30/2026	NON-COMPETING CONTINUATION	-$80
														Subtotal = -$80

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	001	5	8/26/2025	NON-COMPETING CONTINUATION	$0
2025	2023	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	5	5/23/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $339,750 )
2023	2023	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	5	4/13/2023	NON-COMPETING CONTINUATION	$339,750
														Subtotal = $339,750

Issue Date FY: 2022 ( Subtotal = $339,750 )
2022	2022	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	4	4/25/2022	NON-COMPETING CONTINUATION	$339,750
														Subtotal = $339,750

Issue Date FY: 2021 ( Subtotal = $339,750 )
2021	2021	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	3	4/12/2021	NON-COMPETING CONTINUATION	$339,750
														Subtotal = $339,750

Issue Date FY: 2020 ( Subtotal = $339,750 )
2020	2020	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	2	4/16/2020	NON-COMPETING CONTINUATION	$339,750
														Subtotal = $339,750

Issue Date FY: 2019 ( Subtotal = $339,750 )
2019	2019	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Environmental Health	000	1	6/20/2019	NEW	$339,750
														Subtotal = $339,750

Grand Total All Awards = $1,698,670

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses

Award Number: R01ES030425

ORGANIZATION: NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2019

PERIOD OF PERFORMANCE END DATE: 04/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer